Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 242,300 shares at $6.43 ($1.6M) on 2022-09-12, disclosed to the SEC on 2022-09-14.
Open-market sale of $1.6M CTIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |